RNA drug discovery, with atomic precision.
At Atomic AI, we are harnessing the cutting-edge fusion of machine learning and structural biology to unlock the next generation of RNA-centric medicines, from RNA-targeted small molecules to RNA-based therapeutics.
Our foundation model ATOM-1 allows for the world’s most precise predictions of the three-dimensional structure of RNA and is opening up an unprecedented swath of previously inaccessible targets.
Our Platform
Our proprietary R&D platform leverages state-of-the-art deep learning models, integrated into a virtuous cycle with purpose-built, in-house wet-lab assays, to create the next generation of RNA-centric medicines.